SCHEMBL4672126

SCHEMBL4672126

COc1ccc(CCCn2nnn(-c3ccc(N)cc3)c2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.42
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NR1H3 Q13133 2/20 0.40
CYP19A1 P11511 1/20 0.40
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
ROCK2 O75116 1/20 0.39
CYP2C9 P11712 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
DRD2 P14416 1/20 0.38
CALM1 P0DP23 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672123 0.86 MAPKAPK2 (0.46) NPBWR1SMN1; SMN2LMNAMAPTDRD2
SCHEMBL4672086 0.84 KCNJ1 (0.53) SMN1; SMN2LMNAMAPTMAPK1
SCHEMBL4673358 0.84 MAOB (0.46) GSK3AGSK3BLMNASIGMAR1ROCK2
SCHEMBL4670427 0.75 ADORA2B (0.41) SMN1; SMN2CYP19A1LMNAROCK2
SCHEMBL6300285 0.75 NPC1 (0.41) SIGMAR1DRD2
SCHEMBL4670482 0.75 DHODH (0.36) NPBWR1LMNAROCK2CYP2C9TDP1
Hydrochloric Acid SCHEMBL9384727 0.74 ADORA2B (0.40) SMN1; SMN2CYP19A1LMNAMAPTROCK2
SCHEMBL9385608 0.72 DRD2 (0.58) SMN1; SMN2LMNAMAPTTDP1DRD2
SCHEMBL4673352 0.70 MAPK1 (0.50) ROCK2MAPK1
Water SCHEMBL4672111 0.69 ADRB2 (0.42) SMN1; SMN2CYP19A1MAPTNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054881-B1 NOVEL SULFONAMIDE SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS BAYER CORP (US) 2008-07-30 EP disclosed